GLP-1 Semaglutide Injection

Medically-guided GLP-1 therapy that targets appetite regulation for sustainable weight loss

Introduction

GLP-1 Semaglutide Injection for Weight Loss

Crash diets and extreme exercise plans often fail because they work against your biology rather than with it.

GLP-1 semaglutide injection is a doctor-prescribed treatment used in medical weight loss programmes in Singapore, designed to target the hormonal and neurological pathways that drive hunger, cravings, and portion control.

As a GLP-1 receptor agonist, semaglutide works by mimicking glucagon-like peptide-1, a naturally occurring hormone involved in appetite regulation and metabolic control. This allows for reduced caloric intake, improved portion control, and gradual fat reduction under structured medical supervision.

How

GLP-1 Injection Works for Weight Loss

GLP-1 receptors are located in areas of the brain that regulate satiety and food intake. When a GLP-1 semaglutide injection is administered, it activates these receptors to enhance fullness signalling and reduce hunger cues.

As a GLP-1 receptor agonist, semaglutide injection works by:

  • Increasing feelings of fullness

  • Reducing hunger and food cravings

  • Slowing gastric emptying

  • Improving insulin response

  • Supporting steady, sustainable weight reduction

Through appetite regulation and metabolic modulation, GLP-1 injection therapy helps patients achieve structured weight loss within a medically supervised programme.

Clinical studies have shown that GLP-1 receptor agonists may support clinically meaningful weight reduction when used as part of a comprehensive medical weight management plan. Individual results vary, and treatment suitability must be assessed by a doctor.

Who

Is Suitable for GLP-1 Semaglutide Injection

GLP-1 semaglutide injection may be considered for adults seeking doctor-supervised medical weight loss in Singapore.

In general, GLP-1 semaglutide injections may be appropriate for individuals who:

  • Have a Body Mass Index (BMI) of 23 or above based on Asian risk criteria

  • Have excess body weight associated with metabolic risk factors

  • Have experienced difficulty achieving sustained weight reduction through diet and exercise alone

  • Are medically suitable following clinical evaluation

In certain cases, individuals with a BMI slightly below the threshold may be considered if they have weight-related metabolic risk factors or other clinical indications.

GLP-1 injection is a prescription medication and suitability is determined on a case-by-case basis following medical evaluation by a doctor to ensure that the treatment is appropriate and safe.

What

To Expect During GLP-1 Semaglutide Treatment

Weekly Administration

GLP-1 semaglutide injections are administered once weekly as a subcutaneous injection, typically into the abdomen, thigh, or upper arm. The once-weekly injection helps maintain consistent appetite regulation and steady therapeutic levels.

During your first visit, a doctor will guide you on proper injection technique and the dosing schedule.

Dose Escalation and Monitoring

The treatment usually starts at a lower dose to help the body adjust and minimise potential side effects. The dose may be increased gradually over several weeks depending on tolerance, weight loss response, metabolic profile, and clinical goals.

Follow-Up Consultations

After starting GLP-1 semaglutide injection, patients typically have follow-up consultations with our doctors once a month. During these visits, our doctors monitor side effects and overall tolerance to ensure the treatment remains safe and manageable.

They will also assess weight loss progress and review metabolic markers to track effectiveness. If needed, the dosage may be adjusted based on individual response, tolerance, and treatment goals.

Each consultation provides an opportunity to review overall health and discuss next steps, ensuring that the therapy is tailored to each patient’s needs and supports sustainable weight reduction.

FAQ

Frequently Asked Questions

What happens if I stop GLP-1 semaglutide treatment?

Most patients find the injections very manageable. The injection is subcutaneous, usually into the abdomen, thigh, or upper arm, and is designed for comfort and ease of use.

Any mild discomfort is brief, and minor redness or swelling usually resolves quickly. With guidance from our doctors, most people feel confident self-administering their weekly injection at home, making it a simple and low-stress part of their routine.

The most common side effects are generally gastrointestinal, including nausea, bloating, and mild diarrhea. These effects are often temporary and tend to decrease as the body adjusts to the medication. Regular follow-up consultations allow doctors to monitor side effects, adjust dosage if necessary, and ensure treatment safety.